Stock Report

All about this stock under one free report Last Updated: 04-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Medicamen Organics Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: MEDIORG

₹26.50

up-down-arrow ₹0.85 (3.31%)

As on 04-Sep-2026 15:31IST

Market cap

info icon

₹39 Cr

Revenue (TTM)

info icon

₹38 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 46.76 20.92 --
EBIT -- -- 20.31 110.69 --
Net Profit -- -- 24.64 218.33 --
EPS -- -- -8.39 154.80 --
Book Value -- -- 39.57 22.87 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info 11.39--15.3915.90--
Net Margin info 7.66--10.579.96--
Return on equity info 15.95--18.1317.20--
Return on Capital info 15.04--16.9718.21--
Return on Assets info 5.81--8.296.83--
Debt to Equity (x) info ----0.420.83--

Profitability

View Detailed Peer Comparison

ROCE

16.97

Higher than Peers by 0.52

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
16.97
18.21
--
--
--
Peer Median
16.46
15.49
17.37
17.62
--
ROE

18.13

Higher than Peers by 4.26

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
18.13
17.20
--
--
--
Peer Median
13.87
14.72
15.70
18.36
--
ROA

8.29

Higher than Peers by 0.25

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
8.29
6.83
--
--
--
Peer Median
8.04
7.19
9.43
9.43
--
EBIT Margin

15.39

Higher than Peers by 5.35

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
15.39
15.90
--
--
--
Peer Median
10.05
10.28
13.90
17.27
--
Net Margin

10.57

Higher than Peers by 1.46

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
10.57
9.96
--
--
--
Peer Median
9.11
6.78
10.91
12.99
--
Cash Profit Margin

12.53

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
12.53
13.23
--
--
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

51.11

Higher than Peers by 43.94

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
51.11
--
--
--
--
Peer Median
7.17
10.56
12.63
15.47
--
EBIT Growth

46.30

Higher than Peers by 34.25

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
46.30
--
--
--
--
Peer Median
12.05
6.17
-2.90
51.73
--
Net Profit Growth

54.22

Higher than Peers by 32.07

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
54.22
--
--
--
--
Peer Median
22.15
27.97
-14.10
44.15
--
EPS Growth

13.36

Higher than Peers by 4.55

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
13.36
--
--
--
--
Peer Median
8.80
--
-3.68
38.52
--
Book Value Growth

92.53

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
92.53
--
--
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.42

Higher than Peers by 0.39

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
0.42
0.83
--
--
--
Peer Median
0.03
0.05
0.14
0.23
--
Short term debt to equity ratio

0.40

--

(Short term borrowings / Net worth)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
0.40
0.81
--
--
--
Peer Median
--
--
--
--
--
Current Ratio

1.67

Lower than Peers by 0.53

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
1.67
1.26
--
--
--
Peer Median
2.20
1.93
1.82
1.75
--
Quick Ratio

1.40

Lower than Peers by 0.32

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
1.40
0.98
--
--
--
Peer Median
1.72
1.59
1.30
1.04
--
Interest Coverage

11.00

Lower than Peers by 1.29

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
11.00
7.85
--
--
--
Peer Median
12.28
12.45
16.98
15.07
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

67.70

Higher than Peers by 41.47

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
67.70
66.08
--
--
--
Peer Median
26.23
23.97
24.57
20.26
--
Asset Turnover

0.78

Higher than Peers by 0.05

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
0.78
0.66
--
--
--
Peer Median
0.74
0.88
0.82
0.79
--
Receivable days

203.36

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
203.36
241.20
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

65.15

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
65.15
88.72
--
--
--
Peer Median
--
--
--
--
--
Payable days

286.26

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
286.26
281.84
--
--
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-17.75

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
-17.75
48.07
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

6.27

Lower than Peers by 32.89

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
6.27
--
--
--
--
Peer Median
39.17
40.74
25.97
33.71
--
Price / Book Value

0.86

Lower than Peers by 2.74

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
0.86
--
--
--
--
Peer Median
3.61
3.87
2.79
4.36
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
--
--
--
--
--
Peer Median
0.19
0.20
0.65
0.28
--
EV/EBITDA

5.01

Lower than Peers by 23.78

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
5.01
3.57
--
--
--
Peer Median
28.79
25.41
15.07
23.32
--
Market Cap

25

Lower than Peers by 3,919

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Medicamen Organics
25
--
--
--
--
Peer Median
3,944
2,959
3,742
6,050
--
loading...
loading...
loading...
loading...